Search

Author/Creator Voss, Florian

1. On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies. (20th November 2018)

Authors:
Unkel, Steffen; Amiri, Marjan; Benda, Norbert; Beyersmann, Jan; Knoerzer, Dietrich; Kupas, Katrin; Langer, Frank; Leverkus, Friedhelm; Loos, Anja; Ose, Claudia; Proctor, Tanja; Schmoor, Claudia; Schwenke, Carsten; Skipka, Guido; Unnebrink, Kristina; Voss, Florian; Friede, Tim
Journal:
Pharmaceutical statistics
Issue:
Volume 18:Number 2(2019)
Page Start:
166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists. Issue 8 (13th May 2022)

Authors:
Rebordosa, Cristina; Farkas, Dóra Körmendiné; Montonen, Jukka; Laugesen, Kristina; Voss, Florian; Aguado, Jaume; Bothner, Ulrich; Rothman, Kenneth J.; Zint, Kristina; Mines, Daniel; Ehrenstein, Vera
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 31:Issue 8(2022)
Page Start:
827
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial. Issue 10 (19th July 2022)

Authors:
Assassi, Shervin; Distler, Oliver; Allanore, Yannick; Ogura, Takashi; Varga, John; Vettori, Serena; Crestani, Bruno; Voss, Florian; Alves, Margarida; Stowasser, Susanne; Maher, Toby M.
Journal:
ACR open rheumatology
Issue:
Volume 4:Issue 10(2022)
Page Start:
837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease. Issue 2 (21st June 2021)

Authors:
Deterding, Robin; Griese, Matthias; Deutsch, Gail; Warburton, David; DeBoer, Emily M.; Cunningham, Steven; Clement, Annick; Schwerk, Nicolaus; Flaherty, Kevin R.; Brown, Kevin K.; Voss, Florian; Schmid, Ulrike; Schlenker-Herceg, Rozsa; Verri, Daniela; Dumistracel, Mihaela; Schiwek, Marilisa; Stow...
Journal:
ERJ open research
Issue:
Volume 7:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis. (April 2016)

Authors:
Schlueter, Max; Gonzalez-Rojas, N; Baldwin, Michael; Groenke, Lars; Voss, Florian; Reason, Tim
Journal:
Therapeutic advances in respiratory disease
Issue:
Volume 10:Number 2(2016:Apr.)
Page Start:
89
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase I dose‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. (8th June 2018)

Authors:
Ottmann, Oliver G.; Müller‐Tidow, Carsten; Krämer, Alwin; Schlenk, Richard F.; Lübbert, Michael; Bug, Gesine; Krug, Utz; Bochtler, Tilmann; Voss, Florian; Taube, Tillmann; Liu, Dan; Garin‐Chesa, Pilar; Döhner, Hartmut
Journal:
British journal of haematology
Issue:
Volume 184:Number 6(2019)
Page Start:
1018
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗